Redox active transition metals such as copper present a dilemma to cell: they are dangerous but useful cofactors. Recent discoveries indicate that the cytoplasm of eukaryotic cells has an overcapacity for copper chelation, leaving open the question of how copper proteins obtain this essential cofactor. The long term goal of these studies is to elucidate the intacellular chemistry and cell biology of copper in yeast and humans. Our approach focuses on small soluble metal receptors known as metallochaperones. The metallochaperone hypothesis, described first for the Atx l protein, invokes a class of cytoplasmic metal receptor proteins that function in a 'chaperone-like' manner to guide and protect the metal ion while facilitating appropriate partnerships. The metallochaperone proteins characterized to date, Atx1 and CCS, clearly do not function to protect the cell from metal or oxygen toxicity. Instead, these proteins appear to ensure the safe delivery of the metal ion to its proper intracellular destination. In the process, they this protect the cargo from adventitious reactions and a multitude of alternative binding sites. Elucidating the mechanisms of this processes will provide keys to understanding the chemistry and biology of copper in pathological conditions that involve disorders of metal metabolism such as Wilson and Menkes disease and possibly some forms of amyotrophic lateral sclerosis (ALS). The proposed research test a variety structure-function aspects of human Atx1 and CCS and their interaction with known physiological targets including the Wilson and Menkes disease proteins. Energetic and structural aspects of the chaperone partnerships and metal transfer reactions will be resolved. Both thermodynamic and kinetic mechanism experiments have been designed to test the hypothesis that these metallochaperones function like enzymes: they lower the activation barrier for copper transfer along specific reaction coordinates (i.e., transfer to partner) but maintain higher barriers for transfer to non partner sites. If the proposal that the cytoplasm has an extraordinary overcapacity for copper chelation, then the dynamic aspects of metallochaperone structure and metal transfer chemistry will play a central role in copper trafficking within the cell.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM054111-05
Application #
6334474
Study Section
Metallobiochemistry Study Section (BMT)
Program Officer
Preusch, Peter C
Project Start
1997-02-01
Project End
2005-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
5
Fiscal Year
2001
Total Cost
$320,175
Indirect Cost
Name
Northwestern University at Chicago
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Evanston
State
IL
Country
United States
Zip Code
60201
Raja, Meera R; Waterman, Scott R; Qiu, Jin et al. (2013) A copper hyperaccumulation phenotype correlates with pathogenesis in Cryptococcus neoformans. Metallomics 5:363-71
Schmidt, Bryan; Mahmud, Goher; Soh, Siowling et al. (2011) Design, Implementation, Simulation, and Visualization of a Highly Efficient RIM Microfluidic Mixer for Rapid Freeze-Quench of Biological Samples. Appl Magn Reson 40:415-425
Alvarez, Hamsell M; Xue, Yi; Robinson, Chandler D et al. (2010) Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science 327:331-4
Ahn, Richard W; Chen, Feng; Chen, Haimei et al. (2010) A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer. Clin Cancer Res 16:3607-17
Chen, Haimei; Pazicni, Samuel; Krett, Nancy L et al. (2009) Coencapsulation of arsenic- and platinum-based drugs for targeted cancer treatment. Angew Chem Int Ed Engl 48:9295-9
Chen, Haimei; Ahn, Richard; Van den Bossche, Jeroen et al. (2009) Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol Cancer Ther 8:1955-63
Furukawa, Yoshiaki; O'Halloran, Thomas V (2006) Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. Antioxid Redox Signal 8:847-67
Deng, Han-Xiang; Shi, Yong; Furukawa, Yoshiaki et al. (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A 103:7142-7
Furukawa, Yoshiaki; Fu, Ronggen; Deng, Han-Xiang et al. (2006) Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc Natl Acad Sci U S A 103:7148-53
Culotta, Valeria Cizewski; Yang, Mei; O'Halloran, Thomas V (2006) Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta 1763:747-58

Showing the most recent 10 out of 30 publications